Should I buy or sell Hologic stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HOLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HOLX, but not buy additional shares or sell existing shares. View HOLX analyst ratings or view top-rated stocks .

What is Hologic's stock price target for 2024?

9 brokerages have issued 1 year price objectives for Hologic's shares. Their HOLX share price targets range from $72.00 to $105.00. On average, they expect the company's share price to reach $87.00 in the next twelve months. This suggests a possible upside of 12.2% from the stock's current price. View analysts price targets for HOLX or view top-rated stocks among Wall Street analysts .

How have HOLX shares performed in 2024?

Hologic's stock was trading at $71.45 at the beginning of 2024. Since then, HOLX shares have increased by 8.5% and is now trading at $77.54. View the best growth stocks for 2024 here .

When is Hologic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our HOLX earnings forecast .

How can I listen to Hologic's earnings call?

Hologic will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link .

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) released its quarterly earnings data on Thursday, February, 1st. The medical equipment provider reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.95 by $0.03. The medical equipment provider had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $989.32 million. Hologic had a net margin of 12.98% and a trailing twelve-month return on equity of 18.91%. Hologic's revenue for the quarter was down 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.07 EPS. Read the conference call transcript .

What ETFs hold Hologic's stock?

ETFs with the largest weight of Hologic (NASDAQ:HOLX) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) , VictoryShares THB Mid Cap ESG ETF (MDCP) , VictoryShares Nasdaq Next 50 ETF (QQQN) , Fidelity Women's Leadership ETF (FDWM) , First Trust Indxx Medical Devices ETF (MDEV) , iShares U.S. Medical Devices ETF (IHI) , SPDR S&P Health Care Equipment ETF (XHE) and Invesco S&P 500 Equal Weight Health Care ETF (RYH) .

What guidance has Hologic issued on next quarter's earnings?

Hologic issued an update on its FY 2024 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of 3.970-4.120 for the period, compared to the consensus EPS estimate of 4.000. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion.

What is Steve MacMillan's approval rating as Hologic's CEO?

447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com . Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV) , NVIDIA (NVDA) , Johnson & Johnson (JNJ) , Alibaba Group (BABA) , Walt Disney (DIS) , PayPal (PYPL) , Advanced Micro Devices (AMD) , CVS Health (CVS) , Pfizer (PFE) and Abbott Laboratories (ABT) .

Who are Hologic's major shareholders?

Hologic's stock is owned by many different institutional and retail investors. Top institutional shareholders include Congress Asset Management Co. MA (0.53%), Atwood & Palmer Inc. (0.15%), Perpetual Ltd (0.05%), Czech National Bank (0.02%), Banque Cantonale Vaudoise (0.01%) and First Hawaiian Bank (0.01%). Insiders that own company stock include Benjamin Jordan Cohn , Charles J Dockendorff, Essex D Mitchell , Jan Verstreken , John M Griffin , Karleen Marie Oberton , Scott T Garrett , Sean S Daugherty and Sean S Daugherty . View institutional ownership trends .

How do I buy shares of Hologic?

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Hologic have any subsidiaries?

The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC. Read More

NASDAQ:HOLX

Hologic (HOLX) Stock Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)

Free HOLX Stock Alerts

$77.54

+0.21 (+0.27%)

(As of 04/15/2024 ET)

Compare

Today's Range: $77.26
▼
$78.35
50-Day Range: $73.15
▼
$78.41
52-Week Range: $64.02
▼
$87.88

Volume: 1.61 million shs
Average Volume: 1.50 million shs
Market Capitalization: $18.20 billion

P/E Ratio: 36.75
Dividend Yield: N/A
Price Target: $87.00

Get Hologic alerts:

Hologic MarketRank™ Stock Analysis

Analyst Rating: Hold
2.44 Rating Score
Upside/Downside: 12.2% Upside
$87.00 Price Target
Short Interest: Healthy
1.92% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.69
Upright™ Environmental Score
News Sentiment: 0.55
Based on 17 Articles This Week
Insider Trading: Selling Shares
$2.47 M Sold Last Quarter
Proj. Earnings Growth: 8.71%
From $4.02 to $4.37 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.68 out of 5 stars

Medical Sector

62nd out of 928 stocks

X-Ray Apparatus & Tubes Industry

1st out of 5 stocks

3.2

Analyst's Opinion

Consensus Rating
Hologic has received a consensus rating of Hold. The company's average rating score is 2.44, and is based on 4 buy ratings, 5 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Hologic has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

4.0

Short Interest

Percentage of Shares Shorted
1.92% of the float of Hologic has been sold short.
Short Interest Ratio / Days to Cover
Hologic has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Hologic has recently decreased by 4.52%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Hologic does not currently pay a dividend.
Dividend Growth
Hologic does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Hologic has received a 62.25% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "HPV test kits", "Ultrasound machines", "Private breast cancer diagnostics services", "Blood concentration quick tests", "3d ultrasound imaging software", and "Mammography machines" products. See details.
Environmental Sustainability
The Environmental Impact score for Hologic is -1.69.

2.0

News and Social Media Coverage

News Sentiment
Hologic has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 17 news articles for Hologic this week, compared to 8 articles on an average week.
Search Interest
Only 3 people have searched for HOLX on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
MarketBeat Follows
Only 4 people have added Hologic to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Hologic insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,473,443.00 in company stock.
Percentage Held by Insiders
Only 1.75% of the stock of Hologic is held by insiders.
Percentage Held by Institutions
94.73% of the stock of Hologic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Hologic are expected to grow by 8.71% in the coming year, from $4.02 to $4.37 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Hologic is 36.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.33.
Price to Earnings Ratio vs. Sector
The P/E ratio of Hologic is 36.75, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 176.61.
Price to Earnings Growth Ratio
Hologic has a PEG Ratio of 2.62. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Hologic has a P/B Ratio of 3.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Hologic Stock (NASDAQ:HOLX)

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HOLX Stock News Headlines

March 16, 2024 | insidertrades.com

Hologic, Inc. (NASDAQ:HOLX) Director Scott T. Garrett Sells 16,441 Shares

April 16, 2024 | americanbankingnews.com

Hologic, Inc. (NASDAQ:HOLX) Given Average Recommendation of "Hold" by Brokerages

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

April 15, 2024 | americanbankingnews.com

Hologic, Inc. (NASDAQ:HOLX) Expected to Earn Q2 2025 Earnings of $1.11 Per Share

April 13, 2024 | americanbankingnews.com

Q2 2024 Earnings Forecast for Hologic, Inc. Issued By Zacks Research (NASDAQ:HOLX)

April 12, 2024 | americanbankingnews.com

Needham & Company LLC Reiterates "Buy" Rating for Hologic (NASDAQ:HOLX)

April 11, 2024 | businesswire.com

Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography

April 10, 2024 | nasdaq.com

Benjamin Graham Detailed Fundamental Analysis - HOLX

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

April 4, 2024 | finance.yahoo.com

Those who invested in Hologic (NASDAQ:HOLX) five years ago are up 63%

April 3, 2024 | markets.businessinsider.com

The Analyst Landscape: 4 Takes On Hologic

April 2, 2024 | finance.yahoo.com

Hologic (HOLX) Stock Moves -0.05%: What You Should Know

April 2, 2024 | businesswire.com

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024

March 19, 2024 | finance.yahoo.com

Deeming Mass Layoffs a ‘Failure of Leadership,’ One Company Fine-Tunes a Strategy to Avoid Them

March 15, 2024 | finance.yahoo.com

Director Scott Garrett Sells 16,441 Shares of Hologic Inc (HOLX)

March 12, 2024 | msn.com

Goldman Sachs Shares 25 Prime Stock Selection Prospects

March 8, 2024 | msn.com

Empowering Change: How Hologic is Shaping the Future of Women's Healthcare

March 5, 2024 | finance.yahoo.com

Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing

March 1, 2024 | nasdaq.com

HOLX Makes Notable Cross Below Critical Moving Average

March 1, 2024 | finance.yahoo.com

Here's Why Hologic, Inc.'s (NASDAQ:HOLX) CEO Is Unlikely to Expect A Pay Rise This Year

February 27, 2024 | msn.com

FDA warns of potential risk from Hologic's devices implanted in soft tissue

February 27, 2024 | finance.yahoo.com

UPDATE 1-FDA warns of potential risk from Hologic's devices implanted in soft tissue

February 27, 2024 | reuters.com

FDA warns of potential risk of complications with use of Hologic's devices

February 27, 2024 | finanznachrichten.de

Hologic, Inc.: Hologic to Unveil Groundbreaking AI Research at ECR 2024

February 27, 2024 | finance.yahoo.com

Hologic to Unveil Groundbreaking AI Research at ECR 2024

February 27, 2024 | businesswire.com

Hologic to Unveil Groundbreaking AI Research at ECR 2024

February 26, 2024 | businesswire.com

Hologic to Webcast Presentations at Upcoming Investor Conferences

See More Headlines

Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/01/2024
Today: 4/16/2024
Next Earnings (Confirmed): 5/02/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: Health Care Equipment
Current Symbol: NASDAQ:HOLX
CUSIP: 43644010
CIK: 859737
Web: www.hologic.com
Phone: (508) 263-2900
Fax: 781-890-8031
Employees: 6,990
Year Founded: 1985

Price Target and Rating

Average Stock Price Target: $87.00
High Stock Price Target: $105.00
Low Stock Price Target: $72.00
Potential Upside/Downside: +12.2%
Consensus Rating: Hold
Rating Score (0-4): 2.44
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): $2.11
Trailing P/E Ratio: 36.75
Forward P/E Ratio: 19.29
P/E Growth: 2.62
Net Income: $456 million
Net Margins: 12.98%
Pretax Margin: 15.83%
Return on Equity: 18.91%
Return on Assets: 10.47%

Debt

Debt-to-Equity Ratio: 0.55
Current Ratio: 3.89
Quick Ratio: 3.18

Sales & Book Value

Annual Sales: $4.03 billion
Price / Sales: 4.52
Cash Flow: $5.35 per share
Price / Cash Flow: 14.49
Book Value: $20.48 per share
Price / Book: 3.79

Miscellaneous

Outstanding Shares: 234,730,000
Free Float: 230,624,000
Market Cap: $18.20 billion
Optionable: Optionable
Beta: 1.00

Social Links

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Stephen P. MacMillan (Age 60)
Chairman, CEO & President
Comp: $4.12M
Ms. Karleen M. Oberton (Age 53)
Chief Financial Officer
Comp: $1.6M
Mr. Essex D. Mitchell (Age 44)
Chief Operating Officer
Comp: $925.29k
Mr. John M. Griffin (Age 63)
General Counsel
Comp: $1.47M
Mr. Jan Verstreken (Age 56)
Group President of International
Comp: $1.44M
Mr. Paul Malenchini
Chief Information Officer
Ryan M. Simon
Vice President of Investor Relations
Mr. Peter P. Dunne (Age 68)
Senior Vice President of Human Resources
Ms. Monica Aguirre Berthelot
VP & Chief of Staff
Mr. Erik S. Anderson (Age 42)
Division President of Breast & Skeletal Health Solutions

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

Should I Buy Hologic Stock? HOLX Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Hologic, Inc.:

Hologic, Inc. develops and supplies diagnostics products, medical imaging systems, and surgical products for women's health, addressing a crucial market segment with high demand.
The company offers innovative Aptima molecular diagnostic assays for detecting various infectious microorganisms, providing cutting-edge solutions for healthcare professionals.
Hologic's diverse product portfolio includes advanced technologies like the ThinPrep System for cytology applications and the Rapid Fetal Fibronectin Test, showcasing a commitment to staying at the forefront of medical advancements.
Recent developments in the company's offerings, such as the Panther Fusion SARS-CoV-2 assay, demonstrate a proactive approach to addressing current healthcare challenges, potentially leading to increased market share.
Investors may find the current stock price of Hologic, Inc. attractive, considering the company's growth potential and position in the health care equipment industry.

Cons

Investors should be bearish about investing in Hologic, Inc. for these reasons:

Market competition in the health care equipment industry is intense, which could potentially impact Hologic's market share and profitability.
Regulatory challenges and changes in healthcare policies may pose risks to the company's operations and financial performance.
Fluctuations in demand for medical imaging systems and surgical products could affect Hologic's revenue streams and overall business stability.
Investing in a company heavily focused on women's health may expose investors to specific market risks associated with this niche segment.
External factors such as global economic conditions or public health crises could influence Hologic's business operations and stock performance unpredictably.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, April 13, 2024. Please send any questions or comments about these Hologic pros and cons to contact@marketbeat.com.

HOLX Stock Analysis - Frequently Asked Questions

Should I buy or sell Hologic stock right now?: 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HOLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HOLX, but not buy additional shares or sell existing shares.
View HOLX analyst ratings or view top-rated stocks.
What is Hologic's stock price target for 2024?: 9 brokerages have issued 1 year price objectives for Hologic's shares. Their HOLX share price targets range from $72.00 to $105.00. On average, they expect the company's share price to reach $87.00 in the next twelve months. This suggests a possible upside of 12.2% from the stock's current price.
View analysts price targets for HOLX or view top-rated stocks among Wall Street analysts.
How have HOLX shares performed in 2024?: Hologic's stock was trading at $71.45 at the beginning of 2024. Since then, HOLX shares have increased by 8.5% and is now trading at $77.54.
View the best growth stocks for 2024 here.
When is Hologic's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our HOLX earnings forecast.
How can I listen to Hologic's earnings call?: Hologic will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.
How were Hologic's earnings last quarter?: Hologic, Inc. (NASDAQ:HOLX) released its quarterly earnings data on Thursday, February, 1st. The medical equipment provider reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.95 by $0.03. The medical equipment provider had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $989.32 million. Hologic had a net margin of 12.98% and a trailing twelve-month return on equity of 18.91%. Hologic's revenue for the quarter was down 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.07 EPS.
Read the conference call transcript.
What ETFs hold Hologic's stock?: ETFs with the largest weight of Hologic (NASDAQ:HOLX) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), VictoryShares THB Mid Cap ESG ETF (MDCP), VictoryShares Nasdaq Next 50 ETF (QQQN), Fidelity Women's Leadership ETF (FDWM), First Trust Indxx Medical Devices ETF (MDEV), iShares U.S. Medical Devices ETF (IHI), SPDR S&P Health Care Equipment ETF (XHE) and Invesco S&P 500 Equal Weight Health Care ETF (RYH).

What guidance has Hologic issued on next quarter's earnings?: Hologic issued an update on its FY 2024 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of 3.970-4.120 for the period, compared to the consensus EPS estimate of 4.000. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion.
What is Steve MacMillan's approval rating as Hologic's CEO?: 447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.
What other stocks do shareholders of Hologic own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).
Who are Hologic's major shareholders?: Hologic's stock is owned by many different institutional and retail investors. Top institutional shareholders include Congress Asset Management Co. MA (0.53%), Atwood & Palmer Inc. (0.15%), Perpetual Ltd (0.05%), Czech National Bank (0.02%), Banque Cantonale Vaudoise (0.01%) and First Hawaiian Bank (0.01%). Insiders that own company stock include Benjamin Jordan Cohn, Charles J Dockendorff, Essex D Mitchell, Jan Verstreken, John M Griffin, Karleen Marie Oberton, Scott T Garrett, Sean S Daugherty and Sean S Daugherty.
View institutional ownership trends.
How do I buy shares of Hologic?: Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Hologic have any subsidiaries?: The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More

This page (NASDAQ:HOLX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial